Literature DB >> 2813661

Clozapine. Scientific update meeting. Montreux, Switzerland. October 31-November 1, 1988. Proceedings.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2813661

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  7 in total

1.  The trial use of clozapine for abnormal involuntary movement disorders.

Authors:  E D Caine; R J Polinsky; R Kartzinel; M H Ebert
Journal:  Am J Psychiatry       Date:  1979-03       Impact factor: 18.112

2.  The risks and benefits of clozapine versus chlorpromazine.

Authors:  J Claghorn; G Honigfeld; F S Abuzzahab; R Wang; R Steinbook; V Tuason; G Klerman
Journal:  J Clin Psychopharmacol       Date:  1987-12       Impact factor: 3.153

3.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

4.  Effect of clozapine in severe tardive dyskinesia: a case report.

Authors:  H Y Meltzer; D J Luchins
Journal:  J Clin Psychopharmacol       Date:  1984-10       Impact factor: 3.153

5.  The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years.

Authors:  L H Lindström
Journal:  Acta Psychiatr Scand       Date:  1988-05       Impact factor: 6.392

6.  Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years.

Authors:  U Juul Povlsen; U Noring; R Fog; J Gerlach
Journal:  Acta Psychiatr Scand       Date:  1985-02       Impact factor: 6.392

7.  Effect of clozapine on human serum prolactin levels.

Authors:  H Y Meltzer; D J Goode; P M Schyve; M Young; V S Fang
Journal:  Am J Psychiatry       Date:  1979-12       Impact factor: 18.112
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.